Catherine Bresner

发表

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Joshua B. Singer, Darren L. Smith, Shane A. McCarthy, 2021, The Lancet Infectious Diseases.

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

Darren L. Smith, Evelien M. Adriaenssens, Gemma L. Kay, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

D. A. Jackson, Graham W. Taylor, William L. Hamilton, 2020, Cell.

Genomic reconstruction of the SARS-CoV-2 epidemic in England

William T. Harvey, William L. Hamilton, Richard J. Goater, 2021, Nature.

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Graham W. Taylor, Joshua B. Singer, Scott M Elliott, 2021, Nature.

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

of Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

D. A. Jackson, Graham W. Taylor, William L. Hamilton, 2021 .

SARS-CoV-2 evolution during treatment of chronic infection

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

William T. Harvey, Graham W. Taylor, William L. Hamilton, 2021, Cell Reports.

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

William T. Harvey, Scott M Elliott, Robert M. Davies, 2022, Nature Microbiology.

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant

Graham W. Taylor, Joshua B. Singer, Darren L. Smith, 2021, Science.

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Joshua B. Singer, David A. Drew, Scott M Elliott, 2021, The Lancet. Public health.

SARS-CoV-2 evolution during treatment of chronic infection

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning

William T. Harvey, Scott M Elliott, Kevin R. Cole, 2022, Scientific Reports.

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

Scott M Elliott, Kevin R. Cole, Robert M. Davies, 2022, Scientific Reports.

Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

William T. Harvey, Scott M Elliott, Robert M. Davies, 2022, Nature Microbiology.